NOXOPHARM LIMITED

NOX
End-of-day quote. End-of-day quote  - 10/19
0.53AUD -6.19%
Valuation
Fiscal Period: June 2020 2021
Capitalization1 35,2186
Entreprise Value (EV)1 33,1159
P/E ratio -82,5x-18,2x
Yield --
Capitalization / Revenue 4 247 405x33 148 126x
EV / Revenue 3 993 840x28 432 489x
EV / EBITDA -4,18x-11,0x
Price to Book 2,73x4,56x
Nbr of stocks (in thousands) 213 201288 222
Reference price (AUD) 0,170,65
Announcement Date 08/26/202108/26/2021
Previous period Next period
1 AUD in Million
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: June 2020 2021
Net sales 8,285,61
EBITDA1 -7,92-14,5
Operating profit (EBIT)1 -8,08-14,6
Operating Margin -97,6%-260%
Pre-Tax Profit (EBT)1 -1,00-9,35
Net income1 -0,27-9,35
Net margin -3,29%-167%
EPS2 0,00-0,04
Dividend per Share --
Announcement Date 08/26/202108/26/2021
Previous period Next period
1 AUD in Million
2 AUD
Finances - Leverage
Fiscal Period: June 2020 2021
Net Debt1 --
Net Cash position1 2,1026,4
Leverage (Debt / EBITDA) 0,27x1,82x
Free Cash Flow -10,6-4,96
ROE (Net Profit / Equities) -17,5%-34,8%
Shareholders' equity1 1,5526,8
ROA (Net Profit / Asset) -41,5%-26,9%
Assets1 0,6634,8
Book Value Per Share2 0,060,14
Cash Flow per Share2 0,030,09
Capex1 0,00-
Capex / Sales 0,04%-
Announcement Date 08/26/202108/26/2021
Previous period Next period
1 AUD in Million
2 AUD
EPS & Dividend